MEEDER ASSET MANAGEMENT INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2023$136,944
-8.1%
5,8850.0%0.01%
-15.4%
Q4 2022$148,949
+351.4%
5,885
+246.0%
0.01%
+550.0%
Q3 2022$33,000
+1550.0%
1,701
+1709.6%
0.00%
Q2 2022$2,000
-89.5%
94
-83.2%
0.00%
-100.0%
Q3 2020$19,000
+280.0%
560
+359.0%
0.00%
Q2 2020$5,0001220.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders